Company profile for Tentarix Biotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics. We are led by a seasoned executive team with proven expertise in the field of multi-specific drug discovery. We are committed to hiring and retaining highly qualif...
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics. We are led by a seasoned executive team with proven expertise in the field of multi-specific drug discovery. We are committed to hiring and retaining highly qualified and motivated team members who are passionate about making a difference for patients in the modern drug discovery landscape with our ground-breaking technology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10355 Science Center Drive, Suite 120 San Diego, CA, 92121
Telephone
Telephone
(858) 866 - 8832
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250930139478/en/Tentarix-Biotherapeutics-Strengthens-Executive-Team

BUSINESSWIRE
30 Sep 2025
Tentarix Appoints Andrew D. Kidd as CEO
Tentarix Appoints Andrew D. Kidd as CEO

23 Apr 2024

// BUSINESSWIRE

https://www.businesswire.com/news/home/20240423691725/en

BUSINESSWIRE
23 Apr 2024

https://www.businesswire.com/news/home/20230905378534/en

BUSINESSWIRE
06 Sep 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-ties-up-with-tentarix-cancer-inflammatory-disease-therapies-2023-08-15/

REUTERS
16 Aug 2023

https://www.businesswire.com/news/home/20220520005078/en

BUSINESSWIRE
20 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty